Download PDF
Diabetes aktuell 2014; 12(3): 124-128
DOI: 10.1055/s-0034-1383715
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Renale Denervation – Auswirkung auf Blutdruck und HbA1c

Renal Denervation – Effects on blood pressure and glucose metabolism
Siegfried Eckert
1   Kardiologische Klinik, Herz- und Diabeteszentrum NRW, Universitätsklinikum der Ruhruniversität Bochum, Hypertension Excellence Centre of the ESH
› Author Affiliations
Further Information

Publication History

Publication Date:
23 June 2014 (online)

Also available at
    Permissions and Reprints

Die renale Denervation ist für Patienten mit therapierefraktärer arterieller Hypertonie eine sichere Therapieoption. In offenen randomisierten Studien konnte in Praxismessungen eine signifikante Blutdruckreduktion um 32 ± 12 mmHg nachgewiesen werden, im klinischen Alltag wird eine Blutdruckreduktion bei ca. 70 % der behandelten Patienten beobachtet. Einzelne Untersuchungen zeigen eine Verringerung der Sympathikusaktivität. Positive Einflüsse auf den Glukosemetabolismus werden diskutiert.

Renal denervation offers a safe catheter-based approach for reduction of renal sympathetic drive. Based on present evidence, it appears to be indicated for the treatment of resistant hypertension. More studies are needed to assess its role in the management of less servere forms of hypertension and conditions driven by sympathetic hyperactivity, such as disorders in glucose metabolism.

Key words

resistant hypertension - diabetes - renal denervation - sympathetic activity
 

  • Literatur

  • 1 Heidmann C. Prevalence and temporal trend of known diabetes mellitus: results oft he German Health Interview and Examination Survey of Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 688-677
    Google Scholar
  • 2 Meisinger C. Regional disparities of hypertension prevalence and mangement within Germany. J Hypertens 2006; 24: 293-299
    CrossrefGoogle Scholar
  • 3 Maier W. The Diabetes Collaborative Research of Epidemiologic Studies (DIAB-CORE) consortium. The impact of regional deprivation and individueal socio-ecoomic status on the prevalence of type 2 diabetes in Germany. Diabet Med 2012; 30: 78-86
    Google Scholar
  • 4 Mancia G. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31: 1281-1357
    CrossrefGoogle Scholar
  • 5 Landgraf B. Praxisempfehlungen DDG/DGIM. Therapie des Typ-2-Diabetes. Diabetologie 2013; 8: 93-105
    Article in Thieme ConnectGoogle Scholar
  • 6 Mahfoud F. Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresitenten Hypertonie. Dtsch Med Wochenschr 2011; 136: 2418-2424
    Article in Thieme ConnectGoogle Scholar
  • 7 Berndt C. Resilienz. Das Geheimnis der psychischen Widerstandskraft. DTV 2013; 15-22
    Google Scholar
  • 8 Davis MI. Effectiness of renal denervation therapy for resistant hypertension. J Am Coll Cardiol 2013; 62: 231-241
    CrossrefGoogle Scholar
  • 9 Rippy MK. Cather-based renal sympathetic denervation. Clin Res Cardio 2011; 100: 1095-1001
    Google Scholar
  • 10 Krum H. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle study. Lancet 2009; 373: 1275-1281
    CrossrefGoogle Scholar
  • 11 Böhm M. Renal sympathetic denervation: applications in hypertension and beyond. Nat Rev Cardiol 2013; 10: 465-476
    CrossrefGoogle Scholar
  • 12 Johns EJ. Resistant hypertension and renal denervation: 3 Years on. Lancet 2014; 383: 583-584
    CrossrefGoogle Scholar
  • 13 Brandt MC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Card 2012; 59: 901-909
    CrossrefGoogle Scholar
  • 14 Pokushalov E. A radomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervaton in patients with refractory symptomatic arterial fibrillation and resistant hypertension. J Am Coll Cardiol 2012; 60: 1163-1170
    CrossrefGoogle Scholar
  • 15 Witkowski A. Effect of renal sympathetic denervation on blood pressure, sleep apnoe course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58: 559-565
    CrossrefGoogle Scholar
  • 16 Mahfoud F. Effect of renal sympathetic denervation on glucose metabolism in patients with resitant hypertension: a pilot study. Circulation 2011; 18: 1940-1946
    Google Scholar
  • 17 Schlaich MP. Renal denervation: a potential new treatment modality for polycyctic ovary syndrome?. J Hypertens 2011; 29: 991-996
    CrossrefGoogle Scholar
  • 18 Huang WC. Renal denervation prevents and reverses hyperinsulinemia-iduced hypertension in rats. Hypertension 1998; 32: 249-254
    CrossrefGoogle Scholar
  • 19 Bhatt DL. A controlled trialopf renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
    CrossrefGoogle Scholar